Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Clinical Trial to Evaluate Renamezin in Patients With Chronic Renal Failure
KCT0001875Phase 4Recruiting
- Sponsor
- Daewon Pharm
- Start
- Jan 2016
- Modality
- Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Renamezin in chronic kidney disease (CKD), sponsored by Daewon Pharm. Started Jan 2016; status: recruiting.
02
Drugs
Renamezin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on KCT0001875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001875.